There are so many promising medical advancements happening almost every day. If the trials continue to show promise this could really be a miracle. Prayers up!

Via UPI.

An experimental vaccine therapy shows promise in treating people with deadly glioblastoma brain cancer, researchers behind a small, preliminary study report.

With current standard care, half of glioblastoma patients die within 15 months of diagnosis.

Four of the 11 patients in this study survived for more than five years after vaccine/chemotherapy treatment, the Duke Cancer Institute research team said.

“This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said lead author Dr. Kristen Batich.

“While not a controlled efficacy study, the survival results were surprising, and they suggest the possibility that combining the vaccine with a more intense regimen of this chemotherapy promotes a strong cooperative benefit,” she added in a Duke University news release.

The trial — the first of three required for U.S. approval — was set up to test the safety of the chemotherapy/vaccine combination in 11 patients. Patients received an intensified dose of the chemotherapy drug temozolomide, followed by at least six vaccine injections. The vaccine treatments were well-tolerated, the researchers said.

This section is for comments from's community of registered readers. Please don't assume that Tammy agrees with or endorses any particular comment just because she lets it stand.

You must be logged in to post a comment.